Amgen reports positive trial results for high-cholesterol treatment
The portion of Amgen’s Phase 3 trial of evolocumab that evaluated patients with high cholesterol who cannot tolerate statins has met goals related to percent reduction of low-density lipoprotein cholesterol.
Teledyne shares dip despite jump in Q4 profits
Shares of defense and industrial conglomerate Teledyne Technologies sank 1.6 percent in midday trading on Thursday despite higher sales and profits from the Thousand Oaks-based firm.
Lynda.com hires execs for international push
Carpinteria-based online education firm lynda.com has added four executives to bolster its international growth efforts.
Amgen enters into deals for colon cancer, IBD treatments
Thousand Oaks-based Amgen has entered into two new collaborations, one involving treatment for colon cancer and another regarding therapies for inflammatory bowel disease.
New capital injection brings Suneva Medical total to $70.5M
Suneva Medical, a San Diego aesthetics company with executive offices in Santa Barbara, has raised $35 million in debt and equity financing, bringing its total funding to $70.5 million over the past two years.
Software, squared: ProductPlan makes tools for software product managers
It’s a low-cost, simple-to-use Web application for making and sharing product road maps, keeping everyone on the same page.
Round 2: Atara raises $13.5M as T.O. biotech boom takes hold
Thousand Oaks-based Atara Biotherapeutics has brought on more investors to its second financing round, bringing the total raised to $52 million.
